Skip to main content

The potent anti-inflammatory effect of doxycycline

The mechanism of action of ORACEA Capsules (30mg immediate release and 10 mg delayed-release doxycycline) in the treatment of inflammatory lesions of rosacea is unknown. In a clinical study, the effective formulation of ORACEA Capsules resulted in early and significant inflammatory lesion reduction.

Learn More

ORACEA Capsules are precisely formulated to make a difference

The non-antibiotic dose, immediate- and delayed-release beads, is specifically engineered to remain below the antimicrobial threshold.

Learn More